What's Behind the Rally in Pharma Stocks?

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

What's Behind the Rally in Pharma Stocks?

May 11, 2021

Pharma stocks are in focus today as a US drug-maker issued voluntary licenses to produce its Baricitinib drug in India to help combat the second wave of COVID-19 in India.

US drug-maker Eli Lilly has issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers of generic medicines, Cipla, Lupin and Sun Pharmaceutical Industries to manufacture and distribute Baricitinib in India.

Lilly said it was also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses.

In addition to voluntary licenses, Eli Lilly said it had made donation of 400,000 Baricitinib tablets immediately available through the humanitarian aid organisation, Direct Relief to the Indian government

Recent Developments that are Aiding the Pharma Rally

Market participants were tracking Sun Pharmaceutical Industries, Cipla, and Lupin on the back of above news.

Sun Pharmaceutical Industries share price was up over 2% in the morning session today and was also the top sectoral gainer, rallying 5% in the last two days.

--- Advertisement ---
Automobile Sector's Colossal Disruption Could Make You a Fortune

During any major disruption in a sector, fortunes are created.

And now, we are at the cusp of a major disruption that the automotive sector will experience.

It is the electric vehicles gold rush.

At Equitymaster, we have unearthed a hidden way to ride the 15x EV opportunity so that you could take home potentially life-changing gains in the long run.

You can get all details of the hidden way in our upcoming special online event.

YES, Register Me for FREE

Sun Pharma hit a four-year high of Rs 721.90, up over 2% in intra-day trade today. The stock was trading at its highest level since April 2017.

Apart from above, healthcare stocks including hospital and laboratory operators have also been witnessing buying interest lately after the Reserve Bank of India (RBI) announced additional liquidity to key sectors participating in tackling the coronavirus crisis.

Reserve Bank of India Governor Shaktikanta Das last week said India's central bank will give Rs 500 bn in liquidity to key sectors.

Banks can provide fresh lending support to pathology labs, oxygen suppliers, vaccine makers, and hospitals under the priority-sector classification of lending.

The BSE Healthcare Index gained as much as 2.7% on the back of above news, the most in almost a month to trade just shy of its 52-week high.

Vaccine makers Cadila Healthcare and Dr Reddy's Laboratories have also witnessed buying recently after Pfizer Inc laid out a plan to turn its Covid-19 vaccine into a long-term business.

The US drug maker also boosted this year's guidance for revenue from the jabs to about US$ 26 bn from a previous forecast of around US$ 15 bn.

Pfizer said it expects to deliver 1.6 bn doses this year under contracts signed as of mid-April.

--- Advertisement ---
The Rebirth of India

India's leading research analyst, Tanushree Banerjee, will show our readers how an upcoming mega shift would drastically change the state of the Indian economy...

And how investing in three high-potential stocks at the heart of this rebirth...

...could potentially hand them 100%, 300%, 500%, even 1,000% or more in the long run.

Since you are one of our valued readers, we sincerely urge you to head over here for more details

Strong Performance by Pharma Companies

The recent gains in pharma stocks are also led by a strong performance by pharma companies in the domestic market in April, tie-ups by Indian generic players to market Covid-related drugs and expectations of a double digit growth in the March quarter.

Indian Pharma Market (IPM) sales for April 2021 showed an unprecedented 51.5% growth year-on-year (YoY).

Adjusting for the low base effect and excess Covid sales, April YoY growth is at 17.7%.

Reports suggest that there is likely a component of stocking up as many states entered lockdowns during April.

Equitymaster's View on the Pharma Sector

We reached out to Tanushree Banerjee, Co-Head of Research at Equitymaster, and editor of the premium stock recommendation service StockSelect, for her view on the pharma sector.

Here's what she has to say...

  • The second Covid wave has given a new lease of life to pharma stocks.

    As the sector continues to invest in capacities for new drugs, the profitability will depend on the companies' ability to seek USFDA approval for the plants.

    Or their ability to tie up with MNC pharma for producing variants of their vaccine.

Nifty Pharma Index Hits All-Time High

The Nifty Pharma index hit an all-time high of 14,228, after rising 3.5% in intra-day trade on Monday, led by a strong rally in stocks like Torrent Pharma, Alkem Laboratories, Cadila Healthcare, Aurobindo Pharma, Dr Reddy's Laboratories, Sun Pharma and Divi's Labs.

The index surpassed its previous high of 14,020.70, touched in intra-day trade on 7 April 2015.

Join Today: Equitymaster is on Telegram. Join FREE Today for Exclusive market Updates

Since last month, the Nifty Pharma index has outperformed the NSE Nifty index by surging 15%, against 1.7% gain in the benchmark.

How the BSE Healthcare Index Has Performed Over Last Year

Over the last year, the BSE healthcare index has gained 61% as compared to 56% gains in the BSE Sensex.

For more detailed updates, you can have a look at Indian pharma sector report and Indian pharma sector results on our website.

You can also compare pharma companies with their peers.

Sun Pharma vs Cipla

Sun Pharma vs Lupin

Cipla vs Dr Reddy's Lab

Aurobindo Pharma vs Biocon

Cadila Healthcare vs Divi's Lab

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Monish Vora

Monish Vora is a keen student of the markets and shares his observations through his clear and concise commentary.

Equitymaster requests your view! Post a comment on "What's Behind the Rally in Pharma Stocks?". Click here!


More Views on News

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

All You Need to Know About Primary and Secondary Markets

A look at the various types of primary and secondary markets and the key differences between them.

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Oct 14, 2021 (Close)


  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks